Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1021/acs.chas.0c00035 http://scihub22266oqcxt.onion/10.1021/acs.chas.0c00035 C7216769!7216769!37556240     free     free     free       J+Chem+Health+Saf 2020 ; 27 (3): 160-9 Nephropedia Template TP {{tp|p=37556240|t=2020. COVID-19: A Risk Assessment Perspective |pdf=|usr=}}{{37556240}} gab.com Text COVID-19: A Risk Assessment Perspective JO: J Chem Health Saf http://www.kidney.de/pget.php?&tw=1&pmid=37556240 #FOAvip COVID-19 is a newly emerging viral respiratory disease first identified in Wuhan, China, in December 2019. The disease is caused by the coronavirus SARS-CoV-2, which is related to the viruses that cause SARS and MERS. While the case fatality ratio for COVID-19 (5%) is far lower than that for SARS (11%) and MERS (34%), COVID-19 is spreading relatively uncontrolled at this time across the globe. In contrast, SARS appears to be contained, and MERS is controlled. This paper will explore why COVID-19 is able to progress to a global pandemic that affects our daily lives to an extent not known in recent history. The COVID-19 outbreak and spread will be examined based on the current literature, using a researcher?s perspective of risk assessment and risk mitigation; this approach will be related to public health. Twit Text FOAVip COVID-19: A Risk Assessment Perspective ????J Chem Health Saf http://www.kidney.de/pget.php?&tw=1&pmid=37556240 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=37556240 #FOAvip English Wikipedia <ref>{{Cite pmid|37556240}}</ref> COVID-19: A Risk Assessment Perspective #MMPMID37556240 Schröder I J Chem Health Saf 2020[May]; 27 (3): 160-9 PMID37556240show ga COVID-19 is a newly emerging viral respiratory disease first identified in Wuhan, China, in December 2019. The disease is caused by the coronavirus SARS-CoV-2, which is related to the viruses that cause SARS and MERS. While the case fatality ratio for COVID-19 (5%) is far lower than that for SARS (11%) and MERS (34%), COVID-19 is spreading relatively uncontrolled at this time across the globe. In contrast, SARS appears to be contained, and MERS is controlled. This paper will explore why COVID-19 is able to progress to a global pandemic that affects our daily lives to an extent not known in recent history. The COVID-19 outbreak and spread will be examined based on the current literature, using a researcher?s perspective of risk assessment and risk mitigation; this approach will be related to public health. äCOVID-19: A Risk Assessment Perspective (epmc).pdf DeepDyve Pubget Overpricing